Cargando…

Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs

BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Fiona N., Samora, Jake, Brinkley, Katlyn, Jeong, Haelim, Clinton, Nina, Claborn, Kasey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250267/
https://www.ncbi.nlm.nih.gov/pubmed/35780109
http://dx.doi.org/10.1186/s12954-022-00653-1
_version_ 1784739774781718528
author Conway, Fiona N.
Samora, Jake
Brinkley, Katlyn
Jeong, Haelim
Clinton, Nina
Claborn, Kasey R.
author_facet Conway, Fiona N.
Samora, Jake
Brinkley, Katlyn
Jeong, Haelim
Clinton, Nina
Claborn, Kasey R.
author_sort Conway, Fiona N.
collection PubMed
description BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative study examined the specific ways the pandemic negatively impacted people who use drugs. METHODS: Qualitative interviews with 24 people who use drugs and 20 substance use harm reduction workers were conducted. Data from the qualitative interviews were analyzed using applied thematic analysis to identify emergent themes based on the a priori research goals. RESULTS: Thematic analysis identified several common experiences during the pandemic among people who use drugs. These included mental distress due to financial strain and social isolation; increased drug use; increased risky drug-seeking and use behaviors due to changes in the drug markets; and reduced access to harm reduction, treatment, and recovery support services. CONCLUSIONS: Our study highlighted critical systemic failures that contributed to the rise in overdose deaths during the COVID-19 pandemic. Addressing these challenges through policy reform and improved funding models will ensure the sustainability of harm reduction services and increase access to substance use treatment among highly vulnerable people who use drugs.
format Online
Article
Text
id pubmed-9250267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92502672022-07-03 Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs Conway, Fiona N. Samora, Jake Brinkley, Katlyn Jeong, Haelim Clinton, Nina Claborn, Kasey R. Harm Reduct J Research BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative study examined the specific ways the pandemic negatively impacted people who use drugs. METHODS: Qualitative interviews with 24 people who use drugs and 20 substance use harm reduction workers were conducted. Data from the qualitative interviews were analyzed using applied thematic analysis to identify emergent themes based on the a priori research goals. RESULTS: Thematic analysis identified several common experiences during the pandemic among people who use drugs. These included mental distress due to financial strain and social isolation; increased drug use; increased risky drug-seeking and use behaviors due to changes in the drug markets; and reduced access to harm reduction, treatment, and recovery support services. CONCLUSIONS: Our study highlighted critical systemic failures that contributed to the rise in overdose deaths during the COVID-19 pandemic. Addressing these challenges through policy reform and improved funding models will ensure the sustainability of harm reduction services and increase access to substance use treatment among highly vulnerable people who use drugs. BioMed Central 2022-07-02 /pmc/articles/PMC9250267/ /pubmed/35780109 http://dx.doi.org/10.1186/s12954-022-00653-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Conway, Fiona N.
Samora, Jake
Brinkley, Katlyn
Jeong, Haelim
Clinton, Nina
Claborn, Kasey R.
Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title_full Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title_fullStr Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title_full_unstemmed Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title_short Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
title_sort impact of covid-19 among people who use drugs: a qualitative study with harm reduction workers and people who use drugs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250267/
https://www.ncbi.nlm.nih.gov/pubmed/35780109
http://dx.doi.org/10.1186/s12954-022-00653-1
work_keys_str_mv AT conwayfionan impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs
AT samorajake impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs
AT brinkleykatlyn impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs
AT jeonghaelim impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs
AT clintonnina impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs
AT clabornkaseyr impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs